Follow-up strategies after trimodal treatment for muscle-invasive bladder cancer: a systematic review.
Ernest KaufmannStefanie AeppliWinfried ArnoldPanagiotis BalermpasJörg BeyerUwe BieriRichard CathomasBerardino de BariMarco DresslerDaniel S EngelerAndreas ErdmannAndrea GallinaSilvia GomezMatthias GuckenbergerThomas R W HerrmannThomas HermannsLucca IlariaHubert JohnThomas M KesslerJan KleinMohamed LaouitiDavid LaufferAgostino MatteiMichael MüntenerDaniel NguyenPhilipp NiederbergerAlexandros PapachristofilouLukas PrauseKarsten ReinhardtEmanuela SalatiPhilippe SèbeMohamed ShelanRäto StrebelArnoud J TempletonUrsula VoglMarian S WettsteinDeborah ZihlerThomas ZilliDaniel ZwahlenBeat RothChristian Daniel FankhauserPublished in: World journal of urology (2024)
Randomized prospective studies should focus on evaluating the impact of specific follow-up protocols on oncological and functional outcomes following trimodal treatment for muscle-invasive bladder cancer. It is crucial to evaluate personalized adaption of follow-up protocols based on established risk factors, as there is potential for improved patient outcomes and resource allocation.